Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-02-20 00:50 | 2021-02-17 | DBTX | N/A | GLAXOSMITHKLINE PLC | Director | Other | BUY | $18.00 | 150,000 | $2,700,000 | 1,183,663 | +14.5% |
| 2021-02-20 02:17 | 2021-02-17 | TLIS | N/A | BAKER BROS. ADVISORS LP | Director, 10% owner | Other | BUY | $16.00 | 6,250,000 | $100,000,000 | 7,003,176 | +829.8% |
| 2021-02-20 01:54 | 2020-03-03 | N/A | N/A | KKR Financial Holdings LLC | 10% owner | Other | BUY | $25.00 | 1,960,000 | $49,000,000 | 4,000,000 | +96.1% |
| 2021-02-20 00:52 | 2021-02-17 | CRVS | Corvus Pharmaceuticals, Inc. | ORBIMED ADVISORS LLC | Director, 10% owner | Pharmaceutical Preparations | BUY | $3.50 | 1,285,714 | $4,499,999 | 8,053,298 | +19.0% |
| 2021-02-20 03:09 | 2021-02-17 | DBTX | N/A | ORBIMED ADVISORS LLC | Director, 10% owner | Other | BUY | $18.00 | 1,666,666 | $29,999,988 | 883,418 | +100.0% |
| 2021-02-19 05:07 | 2021-02-16 | BMBL | Bumble Inc. | Herd Whitney Wolfe | Director, Officer, 10% owner - CEO & Director | Services-Computer Programming, Data Processing, Etc. | BUY | $43.00 | 488,371 | $20,999,953 | 23,255 | +100.0% |
| 2021-02-18 23:22 | 2021-02-02 | FDEQX | N/A | DURON S COLEMAN TRUST | Officer - Chief Executive Officer | Other | BUY | $50.51 | 1,288,872 | $65,100,925 | 1,288,872 | +100.0% |
| 2021-02-19 01:56 | 2021-02-16 | N-A | N/A | Manulife (International) Ltd | 10% owner | Other | BUY | $21.27 | 385,086 | $8,188,851 | 23,582,033 | +1.7% |
| 2021-02-19 00:37 | 2021-02-16 | N-A | N/A | Manulife Life Insurance Co | 10% owner | Other | BUY | $21.27 | 85,616 | $1,820,621 | 5,242,975 | +1.7% |
| 2021-02-18 22:57 | 2021-02-16 | N-A | N/A | Manufacturers Life Reinsurance Ltd | 10% owner | Other | BUY | $21.27 | 581,147 | $12,358,096 | 35,588,511 | +1.7% |
| 2021-02-18 20:55 | 2021-02-16 | N-A | N/A | Manufacturers Life Insurance Co (Bermuda Branch) | 10% owner | Other | BUY | $21.27 | 116,166 | $2,470,262 | 7,113,795 | +1.7% |
| 2021-02-18 21:36 | 2020-10-16 | N/A | FS Credit Opportunities Corp. | GUARDIAN LIFE INSURANCE CO OF AMERICA | 10% owner | Other | BUY | $100.00 | 25,000,000 | $2,500,000,000 | 60,000,000 | +71.4% |
| 2021-02-19 02:21 | 2021-02-17 | BBIO | BridgeBio Pharma, Inc. | Scott Randal W. | Director | Pharmaceutical Preparations | BUY | $62.50 | 16,000 | $1,000,000 | 21,000 | +320.0% |
| 2021-02-19 02:10 | 2021-02-17 | NUS | NU SKIN ENTERPRISES, INC. | LUND STEVEN | Director, Officer - Exec. Chairman of the Board | Wholesale-Drugs, Proprietaries & Druggists' Sundries | BUY | $48.05 | 20,850 | $1,001,843 | 240,692 | +9.5% |
| 2021-02-19 02:44 | 2021-02-17 | ONCR | N/A | Flynn James E | Director, 10% owner, Other | Other | BUY | $19.00 | 300,000 | $5,700,000 | 345,167 | +664.2% |
| 2021-02-18 01:22 | 2021-01-12 | PACXU | N/A | GERSON RICK MATTHEW | Officer, 10% owner - Co-President | Other | BUY | $10.00 | 4,450,000 | $44,500,000 | 14,392,500 | +44.8% |
| 2021-02-18 03:14 | 2021-02-12 | PRTA | PROTHENA CORP PUBLIC LTD CO | EcoR1 Capital, LLC | 10% owner | Pharmaceutical Preparations | BUY | $21.56 | 633,340 | $13,657,280 | 10,059,980 | +6.7% |
| 2021-02-18 00:30 | 2021-02-12 | LGVN | Longeveron Inc. | Hare Joshua | Director, Officer - Chief Scientific Officer | Pharmaceutical Preparations | BUY | $9.98 | 103,000 | $1,028,228 | 7,998,428 | +1.3% |
| 2021-02-17 21:21 | 2021-02-12 | VTA | N/A | Saba Capital Management, L.P. | 10% owner | Other | BUY | $11.05 | 223,538 | $2,469,536 | 10,062,046 | +2.3% |
| 2021-02-18 02:00 | 2021-02-12 | KKR | KKR & Co. Inc. | SCULLY ROBERT W | Director | Investment Advice | BUY | $48.13 | 26,000 | $1,251,479 | 26,000 | +100.0% |
| 2021-02-18 01:30 | 2021-02-16 | FISV | FISERV INC | OLEARY DENIS | Director | Services-Business Services, NEC | BUY | $110.99 | 9,100 | $1,010,009 | 74,478 | +13.9% |
| 2021-02-18 01:06 | 2021-02-12 | HY | HYSTER-YALE, INC. | BUTLER JOHN C JR | Other | Industrial Trucks, Tractors, Trailors & Stackers | BUY | $59.04 | 104,486 | $6,168,853 | 191,748 | +119.7% |
| 2021-02-18 01:04 | 2021-02-12 | HY | HYSTER-YALE, INC. | WILLIAMS DAVID B | Other | Industrial Trucks, Tractors, Trailors & Stackers | BUY | $59.04 | 104,486 | $6,168,853 | 191,748 | +119.7% |
| 2021-02-18 01:02 | 2021-02-12 | HY | HYSTER-YALE, INC. | BUTLER HELEN RANKIN | Other | Industrial Trucks, Tractors, Trailors & Stackers | BUY | $59.04 | 104,486 | $6,168,853 | 191,748 | +119.7% |
| 2021-02-18 01:01 | 2021-02-12 | HY | HYSTER-YALE, INC. | WILLIAMS CLARA R | Other | Industrial Trucks, Tractors, Trailors & Stackers | BUY | $59.04 | 104,486 | $6,168,853 | 191,748 | +119.7% |
| 2021-02-17 04:35 | 2021-02-04 | PCPL | N/A | Atalan GP, LLC | 10% owner | Other | BUY | $11.03 | 574,500 | $6,336,735 | 4,436,975 | +14.9% |
| 2021-02-17 00:11 | 2020-10-20 | PRAX | Praxis Precision Medicines, Inc. | Vitorovic Stefan | Director | Pharmaceutical Preparations | BUY | $19.00 | 250,000 | $4,750,000 | 2,939,329 | +9.3% |
| 2021-02-17 05:13 | 2021-02-12 | BFLY | Butterfly Network, Inc. | ROBBINS LARRY | Director, 10% owner | X-Ray Apparatus & Tubes & Related Irradiation Apparatus | BUY | $5.24 | 4,774,846 | $25,000,139 | 15,049,846 | +46.5% |
| 2021-02-17 05:52 | 2021-02-11 | DCOM | Dime Community Bancshares, Inc. /NY/ | BASSWOOD CAPITAL MANAGEMENT, L.L.C. | Director, 10% owner, Other | National Commercial Banks | BUY | $26.89 | 45,085 | $1,212,412 | 45,249 | +27,490.9% |
| 2021-02-12 14:51 | 2021-02-10 | PW | Power REIT | Lesser David H | Director, Officer, 10% owner - CEO, Secretary, Treasurer | Real Estate Investment Trusts | BUY | $26.50 | 478,773 | $12,687,485 | 123,020 | +100.0% |
| 2021-02-12 20:44 | 2021-02-10 | VTA | N/A | Saba Capital Management, L.P. | 10% owner | Other | BUY | $11.04 | 170,566 | $1,883,441 | 9,838,508 | +1.8% |
| 2021-02-12 01:03 | 2021-02-09 | GBX | GREENBRIER COMPANIES INC | FURMAN WILLIAM A | Director, Officer - Chairman & CEO | Railroad Equipment | BUY | $43.57 | 50,000 | $2,178,700 | 512,518 | +10.8% |
| 2021-02-12 00:39 | 2021-02-09 | BOLT | Bolt Biotherapeutics, Inc. | Novo Holdings A/S | 10% owner | Pharmaceutical Preparations | BUY | $20.00 | 400,000 | $8,000,000 | 4,503,991 | +9.7% |
| 2021-02-12 05:13 | 2021-02-09 | TUEM | N/A | Lewis John Hartnett | Director, 10% owner | Other | BUY | $1.10 | 954,840 | $1,050,324 | 801,845 | +100.0% |
| 2021-02-12 02:56 | 2019-08-30 | IEA | N/A | ARES MANAGEMENT LLC | Director, 10% owner | Other | BUY | $1,000.00 | 106,606 | $106,606,370 | 27,898 | +100.0% |
| 2021-02-12 02:56 | 2019-08-30 | IEA | N/A | Ares Management Corp | Director, 10% owner | Other | BUY | $1,000.00 | 106,606 | $106,606,370 | 27,898 | +100.0% |
| 2021-02-10 20:20 | 2021-01-26 | VIH | Bakkt, Inc. | Alpine Global Management, LLC | 10% owner | Finance Services | BUY | $14.56 | 525,232 | $7,647,903 | 2,704,899 | +24.1% |
| 2021-02-11 01:30 | 2021-02-08 | KLDO | N/A | Flagship Ventures Fund IV General Partner LLC | 10% owner | Other | BUY | $11.50 | 215,000 | $2,472,500 | 738,333 | +41.1% |
| 2021-02-10 03:56 | 2021-02-05 | LABP | N/A | Poukalov Konstantin | Director, 10% owner | Other | BUY | $12.84 | 250,187 | $3,212,451 | 14,869,915 | +1.7% |
| 2021-02-10 01:15 | 2021-02-09 | VOR | Vor Biopharma Inc. | PARMAR KUSH | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $18.00 | 555,555 | $9,999,990 | 1,858,470 | +42.6% |
| 2021-02-10 02:39 | 2021-02-05 | LHDX | N/A | EPIQ Capital Group, LLC | 10% owner | Other | BUY | $17.00 | 3,461,764 | $58,849,988 | 3,461,764 | +100.0% |
| 2021-02-09 23:08 | 2021-02-09 | TERN | Terns Pharmaceuticals, Inc. | Vivo Capital VIII, LLC | 10% owner | Pharmaceutical Preparations | BUY | $17.00 | 475,000 | $8,075,000 | 357,353 | +100.0% |
| 2021-02-09 23:37 | 2021-02-09 | BOLT | Bolt Biotherapeutics, Inc. | Vivo Capital VIII, LLC | 10% owner | Pharmaceutical Preparations | BUY | $20.00 | 350,000 | $7,000,000 | 150,000 | +100.0% |
| 2021-02-10 02:03 | 2021-02-09 | VOR | Vor Biopharma Inc. | 5AM Ventures VI, L.P. | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $18.00 | 555,555 | $9,999,990 | 1,858,470 | +42.6% |
| 2021-02-10 05:57 | 2021-02-01 | PACE | Nerdy Inc. | LIGHT STREET CAPITAL MANAGEMENT, LLC | 10% owner | Services-Educational Services | BUY | $11.27 | 576,900 | $6,502,586 | 5,077,000 | +12.8% |
| 2021-02-10 02:25 | 2021-02-09 | VOR | Vor Biopharma Inc. | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $18.00 | 2,979,566 | $53,632,188 | 1,825,326 | +100.0% |
| 2021-02-09 23:10 | 2021-02-09 | TERN | Terns Pharmaceuticals, Inc. | GORDON CARL L | Director, 10% owner | Pharmaceutical Preparations | BUY | $17.00 | 475,000 | $8,075,000 | 2,274,723 | +26.4% |
| 2021-02-10 01:21 | 2021-02-05 | OCX | Insight Molecular Diagnostics Inc. | BROADWOOD PARTNERS, L.P. | 10% owner | In Vitro & In Vivo Diagnostic Substances | BUY | $4.50 | 600,000 | $2,700,000 | 16,776,484 | +3.7% |
| 2021-02-09 23:29 | 2021-02-09 | BOLT | Bolt Biotherapeutics, Inc. | HEALY JAMES | Director | Pharmaceutical Preparations | BUY | $20.00 | 450,000 | $9,000,000 | 2,754,437 | +19.5% |
| 2021-02-09 21:32 | 2021-02-05 | N/A | Kayne Anderson BDC, Inc. | LEVITT MICHAEL J | Director, Officer - Chief Executive Officer | Other | BUY | $15.00 | 183,619 | $2,754,285 | 183,619 | +100.0% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.